Pricing Log in Create free account

OmniAb, Inc. (OABI) vs Solid Biosciences Inc. (SLDB)

OmniAb, Inc. and Solid Biosciences Inc. are both Biotechnology companies. OmniAb, Inc. and Solid Biosciences Inc. are of similar size ($704.5M and $662.7M). Solid Biosciences Inc. has the higher net margin (0.00% vs −108.1%) and the higher return on invested capital (0.00% vs −15.8%). Across the 15 metrics below, OmniAb, Inc. leads on 9 and Solid Biosciences Inc. on 6.

Valuation

Metric OABI SLDB Biotechnology median
P/E n/m n/m 10.60
P/S 16.14 88.22 9.40
P/B 2.61 2.90 2.13
Price to free cash flow 272.71 n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 14.54 57.17 9.02
Earnings yield (6.77%) (27.20%) (32.88%)
Free cash flow yield 0.37% (20.18%) (23.13%)

Profitability

Metric OABI SLDB Biotechnology median
Gross margin 97.65% 0.00% 68.51%
Operating margin (115.89%) 0.00% 0.00%
Net margin (108.11%) 0.00% 0.00%
Free cash flow margin 5.92% 0.00% 0.00%
Return on equity (16.51%) (76.87%) (51.96%)
Return on assets (14.48%) (64.86%) (46.06%)
Return on invested capital (15.75%) 0.00% 0.00%

Growth

Metric OABI SLDB Biotechnology median
Revenue growth (TTM) 90.63% — 6.76%
EPS growth (last fiscal year) 6.56% 34.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric OABI SLDB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.21 11.99 4.97
Net debt to EBITDA 1.12 1.05 1.01

Dividend

Metric OABI SLDB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OABI SLDB Biotechnology median
Market cap 704.51m 662.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack